Your session is about to expire
← Back to Search
Film Forming Silicone Gel
Treatment arm for Atrophic Vaginitis
N/A
Waitlist Available
Research Sponsored by Stratpharma AG
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Study Summary
The objective of the study is to determine the efficacy of 7-0940 in the management of atrophic vaginitis in female patients
Eligible Conditions
- Atrophic Vaginitis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Patient-reported Vulvar Quality of Life
Secondary outcome measures
Patient-reported symptoms
Product rating
Severity of overall condition
Trial Design
1Treatment groups
Experimental Treatment
Group I: Treatment armExperimental Treatment1 Intervention
Patients apply 7-0940 at least 2 times daily for 3 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Film forming silicone gel (7-0940)
2022
N/A
~70
Find a Location
Who is running the clinical trial?
Stratpharma AGLead Sponsor
10 Previous Clinical Trials
2,970 Total Patients Enrolled
2 Trials studying Atrophic Vaginitis
2,054 Patients Enrolled for Atrophic Vaginitis
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger